Formation of Cyclophosphamide Specific DNA Adducts in Hematological Diseases

Fanconi anemia (FA) patients are hypersensitive to DNA alkylating agents and require lower doses than non-FA patients to minimize serious toxicity. The mechanism by which hypersensitivity occurs is thought to be due to the inability of these individuals to effectively repair drug-induced interstrand DNA-DNA crosslinks. We recently developed a highly sensitive assay for cyclophosphamide specific … Continued

1 of 1
Back to top
Powered by GlobalLink OneLink Software